Internal Medicine Alert
RSSArticles
-
Possible Benefit From Pharmaceutical-grade Chondroitin on Knee Osteoarthritis
The authors of a European study found a statistically significant and clinically marginally significant reduction in pain at three and six months in patients taking pharmaceutical-grade chondroitin sulfate for knee osteoarthritis.
-
Glucose Self-monitoring May Not Be That Useful
Researchers could not find any statistically significant differences in glycemic control or health-related quality of life between patients who performed glucose self-monitoring compared with those who did not.
-
Early Hot Flashes Could Signal Increased Risk for Heart Disease
Women 42-55 years of age who experience hot flashes are more likely to exhibit poor vascular function.
-
Is This a Typical Flutter?
Atrial flutter is characterized by a special pattern of regular atrial activity that in adults almost always occurs at a rate of 300/minute (250-350/minute range).
-
Clinical Briefs
In this section: the evolution of prostate cancer screening; the limitations of online health information; and treating polycystic ovary syndrome patients.
-
Valbenazine Capsules (Ingrezza)
Valbenazine is indicated for the treatment of tardive dyskinesia in adults.
-
Insomnia Disorder: Evidence for Psychological and Behavioral Interventions
Cognitive behavioral therapy for insomnia is an effective intervention for moderate to severe insomnia disorder and should be considered as an initial treatment.
-
Putting the Genie Back in the Prescription Bottle
Researchers recently developed an evidence-based algorithm for reducing the use of proton pump inhibitors.
-
Clinical Briefs
In this section: Effects of weight gain on the cardiovascular system; comparing sleep apnea treatments; and rhabdomyolysis brought on by exercise.
-
Edaravone Injection (Radicava)
The FDA has approved edaravone, the first new treatment for amyotrophic lateral sclerosis since the approval of riluzole more than 20 years ago.